查看购物车
  • Traditional Chinese
  • English
中东和非洲肠外营养市场预测至 2030 年 - 区域分析 - 按营养类型和最终用户
市场调查报告书
商品编码
1562389

中东和非洲肠外营养市场预测至 2030 年 - 区域分析 - 按营养类型和最终用户

Middle East & Africa Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type and End User
出版日期: | 出版商: The Insight Partners | 英文 84 Pages | 订单完成后即时交付

价格

2022年中东及非洲肠外营养市场价值为2.0888亿美元，预计2030年将达到2.8890亿美元；预计2022年至2030年复合年增长率为4.1%。

营养产品配方创新支撑中东和非洲肠外营养市场

对帮助消费者主动管理健康的产品的需求激增，尤其是那些专注于能量水平、免疫力和疾病治疗等特定需求的产品。营养需求因疾病类型而异。肠外产品的功能和特定配方不会干扰向患者提供的现有治疗，并有助于根据要求提供更精确和增强的治疗。肠外营养的常量营养素和微量营养素配方及其应用根据疾病类型（包括癌症和胃肠道疾病）而有所不同。

创新配方的重大发展带来了营养解决方案的新时代，旨在满足所有个人需求以及每位患者的医疗状况。除了提高肠外营养的有效性之外，这种个人化程度还可以改善患者的治疗效果。配方创新使市场能够充分满足不同患者的独特营养需求，从新生儿、老年人到患有某些疾病的人。例如，稳定性和生物利用度提高的脂基乳剂的出现正在改变静脉营养的面貌，特别是对于早产儿的治疗。此外，由于这些配方创新，传统上与传统营养解决方案相关的问题和副作用的固有风险也降低了。该行业因其在医疗保健生态系统中促进肠外营养的采用和改善患者护理的双重好处而有望实现非凡的增长和长期的成功。因此，营养产品配方的创新预计将为预测期内的市场成长创造机会。因此，营养产品配方的创新是肠外医疗营养市场未来的成长趋势。

中东及非洲肠外营养市场概况

根据统计总局 2020 年年中的报告，沙乌地阿拉伯每年约有 25,000 名早产婴儿。早产儿被放置在保温箱中 30-60 天，政府医院或保险公司可能会花费约 16,000 美元（60,000 沙乌地阿拉伯里亚尔）用于个人治疗和专门护理。如果需要将婴儿保温更长时间，可能会花费约 26,667 美元（100,000 沙特里亚尔）。在这种情况下，营养支持对于获得与同龄婴儿相似的生长速度至关重要，并且可以透过肠内或肠外方式提供。大多数未成熟的早产儿依赖肠外营养，特别是低出生体重（<1,500g）的婴儿。由于与早产相关的严重医疗问题（例如主要器官发育不良、感染和餵食不耐受），此类婴儿不接受肠内餵食。该国卫生部 (MoH) 经营 287 家医院。根据卫生部公布的资料，目前有 236 家医院提供家庭医疗保健，其中一些医院提供家庭肠内营养 (HEN) 或家庭肠外营养 (HPN) 服务，或两者兼有。因此，由于早产数量不断增加，以及政府加强支持和传播民众对肠外营养的认识，沙乌地阿拉伯对肠外营养的需求预计将迅速增长。

中东及非洲肠外营养市场收入及 2030 年预测（百万美元）

中东和非洲肠外营养市场细分

中东和非洲肠外营养市场根据营养素类型、最终用户和国家进行细分。根据营养类型，中东和非洲肠外营养市场分为单剂量胺基酸溶液、肠外脂肪乳、碳水化合物、微量元素以及维生素和矿物质。 2022 年，单剂量胺基酸溶液细分市场占据最大市场份额。

依最终用户划分，中东和非洲肠外营养市场分为医院、诊所等。 2022 年，医院细分市场占据最大的市场份额。

按国家/地区划分，中东和非洲肠外营养市场分为沙乌地阿拉伯、南非、阿联酋以及中东和非洲其他地区。 2022 年，沙乌地阿拉伯在中东和非洲肠外营养市场份额中占据主导地位。

ICU Medical Inc、Grifols SA、辉瑞公司、大冢製药有限公司、百特国际公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd 和 Vifor Pharma Management AG 是中东和非洲地区的一些领先参与者肠外营养市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：中东和非洲肠外营养市场 - 主要产业动态

  • 市场驱动因素
    • 胃肠道疾病盛行率上升
    • 营养不良和早产病例激增
  • 市场限制
    • 与肠外餵食系统相关的机械、胃肠道和代谢併发症
  • 市场机会
    • 中东和非洲地区医疗保健支出不断成长
  • 未来趋势
    • 营养产品配方创新
  • 影响分析

第 5 章：肠外营养市场 - 中东与非洲市场分析

  • 概述
  • 肠外营养市场收入，2020 - 2030

第 6 章：中东和非洲肠外营养市场分析 - 按营养类型

  • 概述
  • 单剂量氨基酸溶液
  • 肠外脂质乳剂
  • 碳水化合物
  • 微量元素
  • 维生素和矿物质

第 7 章：中东和非洲肠外营养市场分析 - 按最终用户

  • 概述
  • 医院
  • 诊所
  • 其他的

第 8 章：中东和非洲肠外营养市场 - 国家分析

  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 中东和非洲其他地区

第 9 章：产业格局

  • 概述
    • 概述

第 10 章：公司简介

  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Vifor Pharma Management AG
  • Aculife Healthcare Pvt Ltd

第 11 章：附录

Product Code: BMIRE00030469

The Middle East & Africa parenteral nutrition market was valued at US$ 208.88 million in 2022 and is expected to reach US$ 288.90 million by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030.

Innovation in Formulations of Nutrition Products Bolster Middle East & Africa Parenteral Nutrition Market

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macronutrient and micronutrient formulations of parenteral nutrition and their applications vary based on the type of disease, including cancer and gastrointestinal diseases.

Significant developments in Innovative formulations bring in a new era of nutritional solutions that are designed to meet all individual demands as well as the medical conditions of each patient. This level of personalization improves patient outcomes in addition to increasing the effectiveness of parenteral nutrition. Formulation innovations enable the market to fully meet the unique nutritional needs of different patients, from newborns and older adults to people with certain medical conditions. For example, the emergence of lipid-based emulsions with improved stability and bioavailability is changing the face of intravenous nourishment, especially for the treatment of premature infants. Additionally, the inherent risks of problems and side effects that have traditionally been connected to conventional nutritional solutions are reduced because of these formulation innovations. The industry is positioned for exceptional growth and long-term success because of its dual benefits of promoting the adoption of parenteral nutrition within the healthcare ecosystem and improving patient care. Thus, innovation in the formulations of nutrition products is anticipated to create opportunities for the market growth during the forecast period. Thus, the innovation in formulations of nutrition products act as future growth trends in the parenteral medical nutrition market.

Middle East & Africa Parenteral Nutrition Market Overview

According to a mid-2020 report from the General Authority for Statistics, ~25,000 babies are born prematurely in Saudi Arabia yearly. The premature babies are placed in incubators for 30-60 days, which can cost government hospitals or insurance companies ~US$ 16,000 (SAR 60,000) for individual treatment and specialized care. If babies are required to be kept in incubation for longer periods, it can cost ~US$ 26,667 (SAR 100,000). In such a scenario, nutritional support is crucial to attain a similar growth rate compared to babies of the same age, and it can be provided through enteral or parenteral ways. Most immature preterm babies depend on parenteral nutrition, especially for babies born with low birth weight (<1,500g). Such babies are not offered enteral feeding due to the severity of medical problems associated with prematurity (such as underdeveloped major organs, infections, and feeding intolerance). The Ministry of Health (MoH) in the country operates 287 hospitals. According to the data published by the MoH, 236 hospitals currently provide home healthcare, of which some either incorporate either home enteral nutrition (HEN) or home parenteral nutrition (HPN), or both services. Therefore, the demand for parenteral nutrition is anticipated to grow rapidly in Saudi Arabia due to the rising number of premature births and increasing government efforts to support and spread awareness among the population regarding parenteral nutrients.

Middle East & Africa Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Parenteral Nutrition Market Segmentation

The Middle East & Africa parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Middle East & Africa parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the Middle East & Africa parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Middle East & Africa parenteral nutrition market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Middle East & Africa parenteral nutrition market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Middle East & Africa Parenteral Nutrition Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rise in Prevalence of Gastrointestinal Diseases
    • 4.1.2 Surge in Cases of Malnutrition and Premature Births
  • 4.2 Market Restraints
    • 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
  • 4.3 Market Opportunities
    • 4.3.1 Growing Healthcare Expenditure in Middle East & Africa Region
  • 4.4 Future Trends
    • 4.4.1 Innovation in Formulations of Nutrition Products
  • 4.5 Impact Analysis

5. Parenteral Nutrition Market - Middle East & Africa Market Analysis

  • 5.1 Overview
  • 5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. Middle East & Africa Parenteral Nutrition Market Analysis - by Nutrient Type

  • 6.1 Overview
  • 6.2 Single Dose Amino Acid Solution
    • 6.2.1 Overview
    • 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Parenteral Lipid Emulsion
    • 6.3.1 Overview
    • 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Carbohydrates
    • 6.4.1 Overview
    • 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Trace Elements
    • 6.5.1 Overview
    • 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Vitamins and Minerals
    • 6.6.1 Overview
    • 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Parenteral Nutrition Market Analysis - by End User

  • 7.1 Overview
  • 7.2 Hospitals
    • 7.2.1 Overview
    • 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Clinics
    • 7.3.1 Overview
    • 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Parenteral Nutrition Market - Country Analysis

  • 8.1 Middle East & Africa
    • 8.1.1 Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 8.1.1.1 Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.1.1 Overview
        • 8.1.1.1.2 Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.1.3 Saudi Arabia: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.1.4 Saudi Arabia: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.2 United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.2.1 Overview
        • 8.1.1.2.2 United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.2.3 United Arab Emirates: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.2.4 United Arab Emirates: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.3 South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.3.1 Overview
        • 8.1.1.3.2 South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.3.3 South Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.3.4 South Africa: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.4 Rest of Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.4.1 Overview
        • 8.1.1.4.2 Rest of Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.4.3 Rest of Middle East & Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.4.4 Rest of Middle East & Africa: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

  • 9.1 Overview
    • 9.1.1 Overview

10. Company Profiles

  • 10.1 ICU Medical Inc
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Grifols SA
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Pfizer Inc
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Otsuka Pharmaceuticals Co Ltd
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Baxter International Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 B Braun SE
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Fresenius Kabi AG
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Vifor Pharma Management AG
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Aculife Healthcare Pvt Ltd
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Parenteral Nutrition Market Segmentation
  • Table 2. Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 3. Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 4. United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 5. United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 6. South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 7. South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 8. Rest of Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 9. Rest of Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 10. Recent Organic Growth Strategies in the Parenteral Nutrition Market
  • Table 11. Glossary of Terms, Parenteral Nutrition Market

List Of Figures

  • Figure 1. Parenteral Nutrition Market Segmentation, By Country
  • Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
  • Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
  • Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
  • Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Middle East & Africa: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 16. Middle East & Africa: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 17. Saudi Arabia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 18. United Arab Emirates: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 19. South Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 20. Rest of Middle East & Africa: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)